Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts
![Replay logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/10/replay-logo-1024x275.png)
San Diego, California and London, UK, October 17, 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced that it has established a scientific advisory board (SAB) comprising ten experts across a broad range of areas of scientific importance in genomic medicine and cell therapy. The newly formed SAB will provide input into […]